Overview of the therapeutic potential of piplartine (piperlongumine)
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2013/02/01
-
Indian UGC (journal)
-
Refrences75
-
Citations224
-
Daniel P. Bezerra
-
Claudia Pessoa
-
Manoel O. de Moraes
-
Nicolau Saker-Neto
-
Edilberto R. Silveira
-
Leticia V. Costa-Lotufo
Cite
Bezerra, Daniel P., et al. “Overview of the Therapeutic Potential of Piplartine (piperlongumine)”. European Journal of Pharmaceutical Sciences, vol. 48, no. 3, 2013, pp. 453-6, https://doi.org/10.1016/j.ejps.2012.12.003.
Bezerra, D. P., Pessoa, C., de Moraes, M. O., Saker-Neto, N., Silveira, E. R., & Costa-Lotufo, L. V. (2013). Overview of the therapeutic potential of piplartine (piperlongumine). European Journal of Pharmaceutical Sciences, 48(3), 453-463. https://doi.org/10.1016/j.ejps.2012.12.003
Bezerra, Daniel P., Claudia Pessoa, Manoel O. de Moraes, Nicolau Saker-Neto, Edilberto R. Silveira, and Leticia V. Costa-Lotufo. “Overview of the Therapeutic Potential of Piplartine (piperlongumine)”. European Journal of Pharmaceutical Sciences 48, no. 3 (2013): 453-63. https://doi.org/10.1016/j.ejps.2012.12.003.
Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV. Overview of the therapeutic potential of piplartine (piperlongumine). European Journal of Pharmaceutical Sciences. 2013;48(3):453-6.
Journal Categories
Medicine
Pharmacy and materia medica
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- In situ-forming hydrogels—review of temperature-sensitive systems
- Thermoresponsive hydrogels in biomedical applications
- Mechanisms of solute release from porous hydrophilic polymers
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells | The Prostate |
| 49 | 2013 |
| Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling | Biochemical and Biophysical Research Communications |
| 63 | 2012 |
| Schistosoma mansoni: In vitro schistosomicidal activity and tegumental alterations induced by piplartine on schistosomula | Experimental Parasitology |
| 58 | 2012 |
Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs | Proceedings of the National Academy of Sciences |
| 182 | 2012 |
| Selective killing of cancer cells by a small molecule targeting the stress response to ROS | Nature |
| 826 | 2011 |
Refrences Analysis
The category
Medicine: Therapeutics. Pharmacology 20
is the most frequently represented among the references in this article. It primarily includes studies from Phytochemistry and Toxicology in Vitro. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The category
Science: Chemistry 70
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation and was published in 2013. The most recent citation comes from a 2024 study titled Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation. This article reached its peak citation in 2020, with 30 citations. It has been cited in 140 different journals, 25% of which are open access. Among related journals, the Molecules cited this research the most, with 18 citations. The chart below illustrates the annual citation trends for this article.